Fredicia Stembridge, NP
Adult Health · Atlanta, GANPI 1134467301
Payments from drug & device makers
Across 78 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$231
- AstraZeneca$199
- Jazz Pharmaceuticals Inc.$168
- Grifols USA, LLC$140
- Insmed, Inc.$124
- Johnson & Johnson$105
- plus $848 from 20 others
What the payments were for
- Food & beverage$1,80299%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 5 | $231 |
| AstraZeneca | 10 | $199 |
| Jazz Pharmaceuticals Inc. | 7 | $168 |
| Grifols USA, LLC | 5 | $140 |
| Insmed, Inc. | 5 | $124 |
| Johnson & Johnson(2 entities) | 6 | $105 |
| Actelion Pharmaceuticals US, Inc. | 5 | $105 |
| Harmony Biosciences LLC | 4 | $99 |
| Boehringer Ingelheim | 3 | $97 |
| Inspire Medical Systems, Inc. | 3 | $73 |
| GSK | 4 | $64 |
| Novartis | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| ZOLL Respicardia, Inc. | 1 | $39 |
| Bayer | 2 | $35 |
| Mylan Specialty L.p. | 2 | $33 |
| Pfizer | 2 | $32 |
| Resmed Corp | 2 | $29 |
| CSL Behring | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Merck | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Gilead | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Inogen, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORENITRAM$123
How this compares
$1,815 in reported general payments places this provider in the 75th percentile of 577 adult health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pramipexole DihydrochloridePramipexole Di-Hcl | 17 | $230 |
| Fluticasone Propionate | 13 | $146 |
| Eszopiclone | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other adult health in Atlanta
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenina LagascaAtlanta$17K
- Caleb MagistroAtlanta$17K
- Charise GleasonAtlanta$14K
- Colleen LewisAtlanta$11K
- Dawnelle StedingAtlanta$9K
- Julie WebsterAtlanta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.